Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
P
251
DELISTED
Pandora Media Inc
P
| $47.8M | 0.09% |
2,240,320
+927,594
| +71% | +$16.3M |
|
|
EQY
252
DELISTED
Equity One
EQY
| $47.8M | 0.09% |
1,962,100
+1,129,333
| +136% | +$27.5M |
|
253
Kroger
KR
$35.5B
| $47.5M | 0.09% |
1,315,913
+1,255,803
| +2,089% | +$46.6M |
|
|
STI
254
DELISTED
SunTrust Banks, Inc.
STI
| $47.2M | 0.09% |
1,234,922
+742,670
| +151% | +$31.1M |
|
|
GNC
255
DELISTED
GNC Holdings, Inc.
GNC
| $47M | 0.09% |
1,163,556
+1,107,159
| +1,963% | +$50.5M |
|
|
256
Bausch Health
BHC
$2.41B
| $46.7M | 0.09% |
261,591
-783,373
| -75% | -$183M |
|
257
CALL
Chevron
CVX
$403B
| $46.6M | 0.09% |
+591,300
| New | +$49.8M |
|
258
East-West Bancorp
EWBC
$17.8B
| $46.4M | 0.09% |
1,208,430
+258,478
| +27% | +$10.9M |
|
259
News Corp Class A
NWSA
$16.4B
| $46.2M | 0.09% |
3,661,778
+1,030,686
| +39% | +$14.3M |
|
260
Newmont
NEM
$139B
| $45.8M | 0.09% |
2,851,330
-997,426
| -26% | -$17.9M |
|
261
Regal Rexnord
RRX
$11.1B
| $45.7M | 0.09% |
809,541
+421,990
| +109% | +$28.2M |
|
262
Fidelity National Financial
FNF
$12.7B
| $45.6M | 0.09% |
1,850,177
+1,380,428
| +294% | +$36.2M |
|
|
PNRA
263
DELISTED
Panera Bread Co
PNRA
| $45.4M | 0.09% |
234,848
-87,976
| -27% | -$16.4M |
|
|
NBIS
264
Nebius Group N.V.
NBIS
$59.6B
| $45.4M | 0.09% |
4,229,137
+3,626,582
| +602% | +$47.3M |
|
265
KeyCorp
KEY
$23.3B
| $45.3M | 0.09% |
3,483,424
-557,492
| -14% | -$7.92M |
|
|
CSC
266
DELISTED
Computer Sciences
CSC
| $45.3M | 0.09% |
1,750,856
+757,784
| +76% | +$20.5M |
|
267
First Solar
FSLR
$23B
| $45.2M | 0.09% |
1,056,748
+858,188
| +432% | +$39.7M |
|
268
Trex
TREX
$4.77B
| $45.2M | 0.09% |
+5,419,596
| New | +$55.7M |
|
|
PTLA
269
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $45.1M | 0.09% |
1,058,315
+637,956
| +152% | +$30.8M |
|
270
Target
TGT
$75.1B
| $45M | 0.09% |
571,924
+276,610
| +94% | +$22.1M |
|
271
Macy's
M
$6B
| $45M | 0.09% |
876,336
+867,911
| +10,302% | +$54.4M |
|
272
Oracle
ORCL
$422B
| $44.9M | 0.09% |
1,242,048
+1,148,286
| +1,225% | +$44.1M |
|
273
HP
HPQ
$27.2B
| $44.8M | 0.09% |
3,855,222
-5,637,327
| -59% | -$73.2M |
|
274
Ralph Lauren
RL
$22.2B
| $44.8M | 0.09% |
379,343
+151,502
| +66% | +$18M |
|
275
Cheniere Energy
LNG
$57.3B
| $44.6M | 0.09% |
922,709
+202,088
| +28% | +$12.5M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.